Steinert clinical trials at UCLA

1 in progress, 0 open to eligible people

Global Study of Del-desiran for the Treatment of DM1
Sorry, not currently recruiting here
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC 1001) for the Treatment of Myotonic Dystrophy Type 1
Los Angeles, California and other locations

Last updated: October 4, 2024